Minaris Advanced Therapies

Minaris Advanced Therapies is a global contract development and manufacturing organization (CDMO) and biosafety testing provider focused exclusively on cell and gene therapies (CGT). The company supports therapy developers from early-stage development through clinical trials and commercial manufacturing, offering services such as process development, GMP manufacturing, and comprehensive analytical testing. Operating under the ownership of Altaris, LLC, Minaris has a significant global footprint with facilities in the United States, Europe, and Asia. The company is known for its deep technical expertise in modalities including CAR-T, TCR-T, viral vectors (AAV, LVV), and various cell-based therapies, helping clients navigate the complex regulatory and operational challenges of bringing advanced therapies to market.